WebBackground: Poly (lactic- co -glycolic acid) (PLGA) has emerged as a promising anticancer drug delivery scaffold. Camptothecin (CPT) has been fabricated into a variety of nano-sized formulations to improve drug action. We report an experimental study on the effect of CPT-encapsulated PLGA (PLGA-CPT) nanoparticles (NPs) on drug-metabolizing ... WebFeb 1, 2000 · Camptothecin (CPT) is a potent topoisomerase I inhibitor that has recently been undergoing phase I clinical trials. Though CPT shows high activity against various …
Molecules Free Full-Text Theoretical Study on the Aggregation …
WebMar 22, 2024 · Antibody–drug conjugate (ADC) is typically composed of a monoclonal antibody (mAbs) covalently attached to a cytotoxic drug via a chemical linker. It combines both the advantages of highly ... WebApr 1, 2011 · 7- tert -Butyldimethylsilyl-10-hydroxycamptothecin (AR-67; also known as DB-67) is a novel lipophilic camptothecin analog in early-phase anticancer clinical trials. In … chippewa county animal shelter mi
Camptothecin: Uses, Interactions, Mechanism of Action - DrugBank
WebJun 13, 2024 · Camptothecin is a potent anticancer drug which inhibits the enzyme, deoxyribonucleic acid topoisomerase I, during the S-phase of cell cycle (Zunino et al. 2002 ). Deoxyribonucleic acid topoisomerase I is an enzyme which is essential for replication and transcription of deoxyribonucleic acid. WebDec 1, 1999 · Camptothecin Resistance: Role of the ATP-binding Cassette (ABC), Mitoxantrone-resistance Half-Transporter (MXR), and Potential for Glucuronidation in MXR-expressing Cells. ... Although the importance of glucuronidation in hepatic drug metabolism is well known, it has received little attention as a possible mechanism of resistance in … WebA recent study confirmed that Camptothecin could downregulate SLC25A6 and induce apoptosis in a mitochondria-dependent pathway . SLC25A6 isoforms are expressed in all tissues and in cultured fibroblasts at levels that depend on the state of oxidative metabolism [ … grape creek login